The quinacrine experience in a population of patients with cutaneous lupus erythematosus and dermatomyositis

J Am Acad Dermatol. 2017 Aug;77(2):374-377. doi: 10.1016/j.jaad.2017.03.027.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Academic Medical Centers
  • Administration, Oral
  • Adult
  • Aged
  • Antimalarials / therapeutic use*
  • Databases, Factual
  • Dermatomyositis / diagnosis
  • Dermatomyositis / drug therapy*
  • Dermatomyositis / epidemiology
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Humans
  • Lupus Erythematosus, Cutaneous / diagnosis
  • Lupus Erythematosus, Cutaneous / drug therapy*
  • Lupus Erythematosus, Cutaneous / epidemiology
  • Male
  • Middle Aged
  • Quinacrine / therapeutic use*
  • Retrospective Studies
  • Severity of Illness Index

Substances

  • Antimalarials
  • Quinacrine